BUND FINANCE

BUND FINANCE › Stocks › PHG

Koninklijke Philips N.V. (PHG)

NYSE · Stock price, chart and technical analysis

US$29.81-0.0800 (-0.27%)

Data from Financial Modeling Prep · Nov 18, 2026, 4:00 PM New York time · may be delayed

Open the live chartSee Technicals⏱ Analyze entryQuarterly earnings📅 See in calendar💬 Explain this move⇄ ComparePractice in the Simulator

Key stats

Previous closeUS$29.89
OpenUS$29.70
Day rangeUS$29.67 – US$30.05
52-week rangeUS$23.62 – US$33.44
Market capUS$29.11B
Volume1.45M
50-day averageUS$26.32
200-day averageUS$27.25
Beta0.92
Last dividend per shareUS$0.9900

Quick technical read

This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it

Fundamentals Annual

Fiscal year20212022202320242025
RevenueEUR 17.2BEUR 17.8BEUR 18.2BEUR 18.0BEUR 17.8B
Net incomeEUR 3.3B−EUR 1.6B−EUR 466.0M−EUR 702.0MEUR 895.0M
EPS (diluted)0.64-1.68-0.49-0.750.93
Gross margin41.8%40.4%41.0%43.1%45.2%
Operating margin3.2%-8.6%-0.6%2.9%8.0%
Net margin19.4%-9.0%-2.6%-3.9%5.0%
Free cash flowEUR 866.0M−EUR 979.0MEUR 1.6BEUR 893.0MEUR 893.0M
Total debtEUR 6.0BEUR 7.3BEUR 7.3BEUR 7.5BEUR 8.1B
CashEUR 2.3BEUR 1.2BEUR 1.9BEUR 2.4BEUR 2.8B

Compound annual growth: revenue 1.0% · net income -27.9% (4 years).

Valuation: today, its history and its sector

Today5-year averageSector median (Healthcare)
P/E—34.5x27.1x
EV / EBITDA—46.9x16.5x
Operating margin10.5%—3.6%
Net margin5.4%—-0.0%
Debt / equity1.42—0.58

Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation. The company reports in another currency: amounts are shown in that currency.

About Koninklijke Philips N.V.

SectorHealthcare
IndustryMedical - Devices
CountryNL
CEORoy W. O. Jakobs
Employees66,401
IPO date1980-03-17

Koninklijke Philips N.V. operates as a leading global healthcare technology enterprise with a presence across North America and numerous international markets. Its operations are organized into three primary divisions: Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses. Within the Diagnosis & Treatment segment, Philips offers advanced diagnostic imaging technologies, including magnetic resonance (MRI), computed tomography (CT), X-ray systems, and innovative detector-based spectral CT solutions, alongside molecular and hybrid imaging for nuclear medicine. The company also provides integrated interventional systems and comprehensive echography (ultrasou…

www.philips.ca

Other stocks on BUND FINANCE

Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice